Aspiriant Risk-Managed Equity Allocation Fund Adv (RMEAX)
17.03
+0.02
(+0.12%)
USD |
Aug 15 2025
Key Stats
Customize
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
1.24% | 1.379B | -- | 19.00% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-174.04M | 11.59% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks long-term capital appreciation while considering federal tax implications of investment decisions. The Fund will hold a broad and diverse group of equity securities of companies in countries with developed and emerging markets with greater emphasis on small capitalization and value companies. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | International Equity |
Broad Category | Equity |
Global Peer Group | Equity Global |
Peer Group | Global Multi-Cap Core |
Global Macro | Equity Global |
US Macro | Developed Global Markets Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Global Funds |
Fund Owner Firm Name | Aspiriant |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
76
-1.188B
Peer Group Low
950.34M
Peer Group High
1 Year
% Rank:
91
-174.04M
-13.92B
Peer Group Low
7.084B
Peer Group High
3 Months
% Rank:
71
-3.152B
Peer Group Low
2.101B
Peer Group High
3 Years
% Rank:
88
-32.88B
Peer Group Low
14.84B
Peer Group High
6 Months
% Rank:
72
-7.024B
Peer Group Low
4.814B
Peer Group High
5 Years
% Rank:
85
-53.87B
Peer Group Low
25.21B
Peer Group High
YTD
% Rank:
70
-8.203B
Peer Group Low
4.435B
Peer Group High
10 Years
% Rank:
26
-109.28B
Peer Group Low
33.24B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of August 16, 2025.
Asset Allocation
As of June 30, 2025.
Type | % Net |
---|---|
Cash | 2.49% |
Stock | 86.20% |
Bond | 2.37% |
Convertible | 0.00% |
Preferred | 0.41% |
Other | 8.53% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
GMO Quality Fund VI | 32.93% | 34.66 | 0.26% |
Rief Strategic Partners Fund
|
8.14% | -- | -- |
Schwab Fundamental EM Equity ETF | 6.20% | 34.38 | 0.06% |
iShares MSCI Global Min Vol Factor ETF | 5.32% | 119.14 | 0.30% |
AQR Large Cap Defensive Style Fund R6 | 4.58% | 21.60 | 0.00% |
Baillie Gifford Emerging Markets Equities Fund K | 4.22% | 23.44 | 0.30% |
GMO Equity Dislocation Investment A USD
|
3.96% | -- | -- |
Viking Global Equities LP
|
3.74% | -- | -- |
iShares MSCI ACWI ETF | 3.40% | 133.38 | 0.02% |
JPMorgan Prime Money Market Fund Institutional | 2.54% | 1.000 | 0.00% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | -- |
Actual Management Fee | 0.11% |
Administration Fee | 913.6K% |
Maximum Front Load | -- |
Maximum Deferred Load | -- |
Maximum Redemption Fee | -- |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 0.00 None |
Minimum Subsequent Investment | 0.00 None |
Basic Info
Investment Strategy | |
The Fund seeks long-term capital appreciation while considering federal tax implications of investment decisions. The Fund will hold a broad and diverse group of equity securities of companies in countries with developed and emerging markets with greater emphasis on small capitalization and value companies. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | International Equity |
Broad Category | Equity |
Global Peer Group | Equity Global |
Peer Group | Global Multi-Cap Core |
Global Macro | Equity Global |
US Macro | Developed Global Markets Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Global Funds |
Fund Owner Firm Name | Aspiriant |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM (8-14-25) | 1.41% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Stock | |
Weighted Average PE Ratio | 27.88 |
Weighted Average Price to Sales Ratio | 6.127 |
Weighted Average Price to Book Ratio | 8.144 |
Weighted Median ROE | 33.23% |
Weighted Median ROA | 11.69% |
ROI (TTM) | 17.79% |
Return on Investment (TTM) | 17.79% |
Earning Yield | 0.0509 |
LT Debt / Shareholders Equity | 0.8044 |
As of June 30, 2025
Growth Metrics
EPS Growth (1Y) | 21.06% |
EPS Growth (3Y) | 14.11% |
EPS Growth (5Y) | 15.81% |
Sales Growth (1Y) | 9.41% |
Sales Growth (3Y) | 10.16% |
Sales Growth (5Y) | 10.26% |
Sales per Share Growth (1Y) | 10.90% |
Sales per Share Growth (3Y) | 11.35% |
Operating Cash Flow - Growth Ratge (3Y) | 11.98% |
As of June 30, 2025
Fund Details
Key Dates | |
Inception Date | 4/4/2013 |
Last Annual Report Date | 3/31/2025 |
Last Prospectus Date | 8/1/2025 |
Attributes | |
Index Fund | -- |
Inverse Fund | -- |
Leveraged Fund | -- |
Fund of Funds | No |
Currency Hedged Fund | -- |
Synthetic Replication Fund | No |
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:RMEAX", "name") |
Broad Asset Class: =YCI("M:RMEAX", "broad_asset_class") |
Broad Category: =YCI("M:RMEAX", "broad_category_group") |
Prospectus Objective: =YCI("M:RMEAX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |